CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading organization profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

University of Massachusetts Lowell - Medical Cannabis Research Engine

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Organizations/education

education organization

University of Massachusetts Lowell

US

OPENALEX: I133738476↗ROR: 03hamhx47↗

People

Connected researchers

Adeyinka AdejumoORCID 0000-0001-5144-4064 Kelechi Lauretta AdejumoExact authorship link Michèle MoreauORCID 0000-0002-6881-6300 Wilfred NgwaORCID 0000-0001-8317-6850

Public evidence

4 connected articles

Corrigendum: Flavonoid Derivative of <i>Cannabis</i> Demonstrates Therapeutic Potential in Preclinical Models of Metastatic Pancreatic Cancer.2020 · PubMed Central Open Access Flavonoid Derivative of Cannabis Demonstrates Therapeutic Potential in Preclinical Models of Metastatic Pancreatic Cancer.2019 · PubMed Central Open Access Reduced Incidence and Better Liver Disease Outcomes among Chronic HCV Infected Patients Who Consume Cannabis.2018 · PubMed Central Open Access Cannabis use is associated with reduced prevalence of non-alcoholic fatty liver disease: A cross-sectional study.2017 · PubMed Central Open Access

Matched by exact identifiers only. Profile data: OpenAlex.